NAD Metabolism and Regulation: Lessons From Yeast

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2020 Feb 26

PMID 32092906

Citations 20

Authors

Trevor Croft

Padmaja Venkatakrishnan

Su-Ju Lin

Affiliations

Soon will be listed here.

Abstract

Nicotinamide adenine dinucleotide (NAD) is an essential metabolite involved in various cellular processes. The cellular NAD pool is maintained by three biosynthesis pathways, which are largely conserved from bacteria to human. NAD metabolism is an emerging therapeutic target for several human disorders including diabetes, cancer, and neuron degeneration. Factors regulating NAD homeostasis have remained incompletely understood due to the dynamic nature and complexity of NAD metabolism. Recent studies using the genetically tractable budding yeast have identified novel NAD homeostasis factors. These findings help provide a molecular basis for how may NAD and NAD homeostasis factors contribute to the maintenance and regulation of cellular function. Here we summarize major NAD biosynthesis pathways, selected cellular processes that closely connect with and contribute to NAD homeostasis, and regulation of NAD metabolism by nutrient-sensing signaling pathways. We also extend the discussions to include possible implications of NAD homeostasis factors in human disorders. Understanding the cross-regulation and interconnections of NAD precursors and associated cellular pathways will help elucidate the mechanisms of the complex regulation of NAD homeostasis. These studies may also contribute to the development of effective NAD-based therapeutic strategies specific for different types of NAD deficiency related disorders.

Citing Articles

Dysfunctional copper homeostasis in affects genomic and neuronal stability.

Weishaupt A, Gremme A, Meiners T, Schwantes V, Sarnow K, Thiel A Redox Biochem Chem. 2024; 10.

PMID: 39726988 PMC: 11671132. DOI: 10.1016/j.rbc.2024.100043.

Protein moonlighting by a target gene dominates phenotypic divergence of the Sef1 transcriptional regulatory network in yeasts.

Hsu P, Lu T, Hung P, Leu J Nucleic Acids Res. 2024; 52(22):13914-13930.

PMID: 39565215 PMC: 11662654. DOI: 10.1093/nar/gkae1147.

Novel Approach to Skin Anti-Aging: Boosting Pharmacological Effects of Exogenous Nicotinamide Adenine Dinucleotide (NAD) by Synergistic Inhibition of CD38 Expression.

Kang S, Park J, Cheng Z, Ye S, Jun S, Kang N Cells. 2024; 13(21.

PMID: 39513906 PMC: 11544843. DOI: 10.3390/cells13211799.

Exploring fermentative metabolic response to varying exogenous supplies of redox cofactor precursors in selected wine yeast species.

Tyibilika V, Setati M, Bloem A, Divol B, Camarasa C FEMS Yeast Res. 2024; 24.

PMID: 39375837 PMC: 11503943. DOI: 10.1093/femsyr/foae029.

Nicotinamide Mononucleotide Supplementation Alleviates Doxorubicin-Induced Multi-Organ Fibrosis.

Wen F, Xu A, Wei W, Yang S, Xi Z, Ge Y Int J Mol Sci. 2024; 25(10).

PMID: 38791345 PMC: 11120852. DOI: 10.3390/ijms25105303.

References

Giasson B, Duda J, Murray I, Chen Q, Souza J, Hurtig H . Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000; 290(5493):985-9. DOI: 10.1126/science.290.5493.985. View

Chen Y, Kowtoniuk W, Agarwal I, Shen Y, Liu D . LC/MS analysis of cellular RNA reveals NAD-linked RNA. Nat Chem Biol. 2009; 5(12):879-81. PMC: 2842606. DOI: 10.1038/nchembio.235. View

Mecocci P, MacGarvey U, Beal M . Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol. 1994; 36(5):747-51. DOI: 10.1002/ana.410360510. View

Camacho-Pereira J, Tarrago M, Chini C, Nin V, Escande C, Warner G . CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metab. 2016; 23(6):1127-1139. PMC: 4911708. DOI: 10.1016/j.cmet.2016.05.006. View

Essuman K, Summers D, Sasaki Y, Mao X, DiAntonio A, Milbrandt J . The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD Cleavage Activity that Promotes Pathological Axonal Degeneration. Neuron. 2017; 93(6):1334-1343.e5. PMC: 6284238. DOI: 10.1016/j.neuron.2017.02.022. View

FRIEDKIN M, Lehninger A . Esterification of inorganic phosphate coupled to electron transport between dihydrodiphosphopyridine nucleotide and oxygen. J Biol Chem. 1949; 178(2):611-44. View

Klaidman L, Morales M, Kem S, Yang J, Chang M, Adams Jr J . Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacology. 2003; 69(3):150-7. DOI: 10.1159/000072668. View

Hecht A, Grunstein M . Spreading of transcriptional repressor SIR3 from telomeric heterochromatin. Nature. 1996; 383(6595):92-6. DOI: 10.1038/383092a0. View

Ghislain M, Talla E, Francois J . Identification and functional analysis of the Saccharomyces cerevisiae nicotinamidase gene, PNC1. Yeast. 2002; 19(3):215-24. DOI: 10.1002/yea.810. View

10.

Yaku K, Okabe K, Hikosaka K, Nakagawa T . NAD Metabolism in Cancer Therapeutics. Front Oncol. 2019; 8:622. PMC: 6315198. DOI: 10.3389/fonc.2018.00622. View

11.

Strand M, Stuart G, Longley M, Graziewicz M, Dominick O, Copeland W . POS5 gene of Saccharomyces cerevisiae encodes a mitochondrial NADH kinase required for stability of mitochondrial DNA. Eukaryot Cell. 2003; 2(4):809-20. PMC: 178377. DOI: 10.1128/EC.2.4.809-820.2003. View

12.

Zhang H, Zhong H, Zhang S, Shao X, Ni M, Cai Z . NAD tagSeq reveals that NAD-capped RNAs are mostly produced from a large number of protein-coding genes in . Proc Natl Acad Sci U S A. 2019; 116(24):12072-12077. PMC: 6575590. DOI: 10.1073/pnas.1903683116. View

13.

Carri M, Valle C, Bozzo F, Cozzolino M . Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS. Front Cell Neurosci. 2015; 9:41. PMC: 4330888. DOI: 10.3389/fncel.2015.00041. View

14.

Thielen J, Ciriacy M . Biochemical basis of mitochondrial acetaldehyde dismutation in Saccharomyces cerevisiae. J Bacteriol. 1991; 173(21):7012-7. PMC: 209057. DOI: 10.1128/jb.173.21.7012-7017.1991. View

15.

Pullman M, SAN PIETRO A, COLOWICK S . On the structure of reduced diphosphopyridine nucleotide. J Biol Chem. 1954; 206(1):129-41. View

16.

Osterloh J, Yang J, Rooney T, Fox A, Adalbert R, Powell E . dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science. 2012; 337(6093):481-4. PMC: 5225956. DOI: 10.1126/science.1223899. View

17.

Pehar M, Harlan B, Killoy K, Vargas M . Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration. Antioxid Redox Signal. 2017; 28(18):1652-1668. PMC: 5962335. DOI: 10.1089/ars.2017.7145. View

18.

Lunn E, Perry V, Brown M, Rosen H, Gordon S . Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve. Eur J Neurosci. 1989; 1(1):27-33. DOI: 10.1111/j.1460-9568.1989.tb00771.x. View

19.

Luttik M, Overkamp K, Kotter P, de Vries S, van Dijken J, Pronk J . The Saccharomyces cerevisiae NDE1 and NDE2 genes encode separate mitochondrial NADH dehydrogenases catalyzing the oxidation of cytosolic NADH. J Biol Chem. 1998; 273(38):24529-34. DOI: 10.1074/jbc.273.38.24529. View

20.

Yang Y, Sauve A . NAD(+) metabolism: Bioenergetics, signaling and manipulation for therapy. Biochim Biophys Acta. 2016; 1864(12):1787-1800. PMC: 5521000. DOI: 10.1016/j.bbapap.2016.06.014. View